alexa Trends in Biomedical Nanotechnology | OMICS International
ISSN: 2155-983X
Journal of Nanomedicine & Biotherapeutic Discovery

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Trends in Biomedical Nanotechnology

Yashveer Singh*

Department of Chemistry, Indian Institute of Technology Ropar, Rupnagar, Punjab, India

*Corresponding Author:
Yashveer Singh
Department of Chemistry
Indian Institute of Technology Ropar
Rupnagar, Punjab, India
Tel: 91-1881-242246
E-mail: [email protected]

Received Date: March 01, 2014; Accepted Date: March 03, 2014; Published Date: March 05, 2014

Citation: Singh Y (2014) Trends in Biomedical Nanotechnology. J Nanomedine Biotherapeutic Discov 4:e130. doi: 10.4172/2155-983X.1000e130

Copyright: © 2014 Singh Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Nanomedicine & Biotherapeutic Discovery

The nanotechnology, as defined by the US National Nanotechnology Initiative (NNI), is fabrication of materials with at least one dimension in 1-100 nm range [1]. The field of nanotechnology has generated tremendous excitement because these materials exhibit fundamental properties that are significantly different from that of bulk material, and are attributable to their small size (≤100 nm). For instance, quantum dots are nanoparticles (2-10 nm) of semi-conducting materials, usually selenides or sulfides of metals like zinc and cadmium. The quantum dots, owing to their nano size, exhibit superior signal brightness, size dependent emission of light, which, is resistant to photo bleaching, contrary to organic fluorescent dyes. Thus by controlling the size of quantum dots, it is possible to control the wavelength of emission for these nanomaterials. The size-based tunable light emission and resistance to photo bleaching observed in quantum dots is attributed to their nano size, and is not present in bulk materials. The main aim of nanotechnology is to take advantage of these unique properties in fabricating novel materials and devices, or developing unique applications.

The major thrust of biomedical nanotechnology is to apply the benefits of nanotechnology to healthcare (e.g., imaging and diagnostics; nanodrugs; drug delivery; prostheses; and implants; etc.) [2,3]. Nanotechnology has been earlier used to improve drug properties. For example, pacliaxel (taxol), an anticancer drug, which is used to treat primary epithelial ovarian carcinoma, breast, colon, and lung cancers, exhibits low water solubility and, therefore, poor bioavailability. Therefore, it was formulated in Chremophor EL (polyethoxylated castor oil), which has been implicated in several drug associated toxicities. To overcome these shortcomings associated with the use of Cremophor, paclitaxel bound to albumin nanoparticles (Abraxane) were developed for clinical use. There is a huge interest in employing nanotechnology for cancer drug delivery. The interest in cancer drug delivery stems from the fact that the nanoparticles passively target tumors by a process called enhanced permeability and retention (EPR) effect, as elucidated by Maeda and coworkers [4-6]. It occurs because the tight junctions between endothelial cells of microvessels measure around 2 nm (6 nm in kidney, liver, and spleen), whereas the pore size of tumor microvessels varies from 100 to 1200 nm. Therefore, nanoparticles of appropriate size are able to extravasate into tumors, and not normal tissues, where they are retained because of slow venous return and poor lymphatic drainage. Another advantage is the fact that nanoparticles possess large surface area, which can be exploited to graft various types of functional groups on to the nanoparticles. For instance, it is possible to graft diagnostics and therapeutic moieties on to the same nanoparticles to combine diagnostics and therapy (theranostics) into one delivery platform [2,3].

Despite the promises that biomedical nanotechnology holds for healthcare, there is a concern, in general about its safety and, in particular, the possibility of causing unforeseen adverse effects [2,3]. The concern that the nanotechnology poses a serious health and environmental risks has impeded the field for a very long time. There is a tremendous need to develop methods to characterize nanomaterials and their interaction with biological systems, to monitor the health and environmental risks posed by the nanotechnology.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 11980
  • [From(publication date):
    August-2014 - Jul 23, 2018]
  • Breakdown by view type
  • HTML page views : 8186
  • PDF downloads : 3794

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7